In New Case, Plaintiff Alleges Yaz Caused Her Gallbladder Complications
On August 21, 2012, a Yaz lawyer filed suit in the Superior Court of Los Angeles County, California, on behalf of a plaintiff seeking damages stemming from her gallbladder removal, which she alleges she suffered as a direct result of ingesting the prescription contraceptive Yaz. The plaintiff is seeking damages from manufacturer Bayer, asserting various negligence and products liability claims, including breach of implied and express warranties, fraudulent concealment and negligent misrepresentation. According to the new complaint, the plaintiff had to have her gallbladder removed on January 4, 2012, through a process known as a cholecystectomy.
Yaz lawyer files suit as part of a coordinated proceeding
After completing a Yaz lawsuit case evaluation and filing suit, the plaintiff’s case was joined with the coordinated proceeding in California state court. Other consolidated cases are pending in federal multidistrict litigation in the Southern District of Illinois, as well as a mass tort at the state court level in New Jersey.
Yaz gallbladder disease may have lifelong effects
Yaz gallbladder disease can cause the afflicted patient to suffer tremendous abdominal pain. Gallbladder removal may decrease the pain, but may also require permanent dietary changes and medical monitoring.
Drug linked to serious complications, including Yaz death
Since it was first introduced on the market in the United States in 2008, Yaz has been linked to serious side effects including blood clots, stroke, deep vein thrombosis, gallbladder disease, heart attack and pulmonary embolism. In several cases, such conditions have led to permanent injury and evenYaz death. Yasmin, the precursor to Yaz, was released in the United States in 2001 and was originally marketed as a superior alternative to other prescription contraceptives on the market, using a unique progestin called drospirenone. Yaz is a derivative of the same product, and Ocella is the name given to the generic version.
As of July 9, it was reported that Bayer had already paid out more than $402.6 million stemming from at least 1,877 cases. However, this is just a fraction of the more than 12,000 Yaz lawsuits that have been filed in courts across the country, and it was recently reported that Bayer expected that settlements could reach up to $1.29 billion.